Plunkett Research Online: Sanofi SA

SANOFI SA (SNY:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company.....



Sanofi SA
Ticker: SNY
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33-1-53-77-40-00
Fax:
Address: 46, avenue de la Grande Armée
Paris, 75017 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
Pharmaceuticals
Research
Development
Vaccines
Diabetes
Cardiovascular
Specialty Care
Contacts Description
Paul HudsonCEO/Director
Jean-Baptiste De ChatillonCFO/Executive VP
See More
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company.....See More See More

Auditor: PRICEWATERHOUSECOOPERS AUDIT
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (EUR)Bonus (EUR)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: